The effect of statins on performance in the Morris water maze in guinea pig

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 287-293

  Maggo, Simran ^a   Clark, David ^a   Ashton, John C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

(Guinea pig); Atorvastatin; Morris water maze; Simvastatin; Statin; Thigmotaxis

Indexed keywords

ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; INTERVENTION STUDY; LOW DRUG DOSE; MALE; MAZE TEST; MORRIS WATER MAZE TEST; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWIMMING; TIME; VELOCITY;

ANIMALS; BIOLOGICAL MARKERS; COGNITION; GUINEA PIGS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MAZE LEARNING;

EID: 84855544320     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.006     Document Type: Article

References (79)

1. Amarenco, P., Bogousslavsky, J., Callahan, A., 2006. High-dose atorvastatin after stroke or transient ischemic attack. J. Vasc. Surg. 44, 1374.
2. Andrews, T.C., Ballantyne, C.M., Hsia, J.A., Kramer, J.H., 2001. Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins. Am. J. Med. 111, 185-191. (Pubitemid 32786945)
3. Balk, E.M., Karas, R.H., Jordan, H.S., Kupelnick, B., Chew, P., Lau, J., 2004. Effects of statins on vascular structure and function: a systematic review. Am. J. Med. 117, 775-790. (Pubitemid 39482531)
4. Bays, H., 2006. Statin safety: an overviewand assessment of the data - 2005. Am. J. Cardiol. 97, S6-S26.
5. Baytan, S.H., Alkanat, M., Okuyan, M., Ekinci, M., Gedikli, E., Ozeren, M., Akgun, A., 2008. Simvastatin impairs spatial memory in rats at a specific dose level. Tohoku J. Exp. Med. 214, 341-349. (Pubitemid 351761052)
6. Benito-León, J., Louis, E.D., Vega, S., Bermejo-Pareja, F., 2010. Statins and cognitive functioning in the elderly: a population-based study. J. Alzheimers Dis. 21, 95-102.
7. Bernick, C., Katz, R., Smith, N.L., Rapp, S., Bhadelia, R., Carlson, M., Kuller, L., Cardiovascular Health Study Collaborative Research, G, 2005. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 65, 1388-1394. (Pubitemid 41552767)
8. Bolego, C., Baetta, R., Bellosta, S., Corsini, A., Paoletti, R., 2002. Safety considerations for statins. Curr. Opin. Lipidol. 13 (6), 637-644. (Pubitemid 36009203)
9. Brugts, J.J., Yetgin, T., Hoeks, S.E., Gotto, A.M., Shepherd, J., Westendorp, R.G.J., de Craen, A.J.M., Knopp, R.H., Nakamura, H., Ridker, P., van Domburg, R., Deckers, J.W., 2009. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338, b2376.
10. Chauhan, N.B., Gatto, R., 2010. Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury. Brain Res. 1360, 177-192.
11. Chen, S.-F., Hung, T.-H., Chen, C.-C., Lin, K.-H., Huang, Y.-N., Tsai, H.-C., Wang, J.-Y., 2007. Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci. 81, 288-298. (Pubitemid 47030572)
12. Cheung, B.M.Y., Lauder, I.J., Lau, C.-P., Kumana, C.R., 2004. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br. J. Clin. Pharmacol. 57, 640-651. (Pubitemid 38582185)
13. Christian, H., 1997. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20, 298-303.
14. Christian, H., 1999. Synaptic Plasticity and Learning and Memory: LTP and Beyond, pp. 62-75.
15. Cimino, M., Balduini, W., Carloni, S., Gelosa, P., Guerrini, U., Tremoli, E., Sironi, L., 2005. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology 26, 929-933. (Pubitemid 41427533)
16. Collins, R., Armitage, J., Parish, S., Sleight, P., Peto, R., 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet 360, 7-22. (Pubitemid 34756487)
17. Davidson, M.H., Clark, J.A., Glass, L.M., Kanumalla, A., 2006. Statin safety: an appraisal from the adverse event reporting system. Am. J. Cardiol. 97, S32-S43.
18. Dietschy, J.M., Turley, S.D., 2004. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397. (Pubitemid 39022664)
19. Dringenberg, H.C., Richardson, D.P., Brien, J.F., Reynolds, J.N., 2001. Spatial learning in the guinea pig: cued versus non-cued learning, sex differences, and comparison with rats. Behav. Brain Res. 124, 97-101. (Pubitemid 32567563)
20. Emily, P.H., 1997. Synaptic plasticity: a role for nitric oxide in LTP. Curr. Biol. 7, R141-R143.
21. Evans, M.A., Golomb, B.A., 2009. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy 29, 800-811.
22. Fernandez, M.L., Volek, J.S., 2006. Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. Nutr. Metab. 3 (17).
23. Frank, C., Giammarioli, A.M., Pepponi, R., Fiorentini, C., Rufini, S., 2004. Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Lett. 566, 25-29. (Pubitemid 38625926)
24. Frank, C., Rufini, S., Tancredi, V., Forcina, R., Grossi, D., D'Arcangelo, G., 2008. Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp. Neurol. 212, 407-414.
25. Galatti, L., Polimeni, G., Salvo, F., Romani, M., Sessa, A., Spina, E., 2006. Short-term memory loss associated with rosuvastatin. Pharmacotherapy 26 (8), 1190-1192. (Pubitemid 44167829)
26. Golomb, B.A., Criqui, M.H., White, H.L., Dimsdale, J.E., 2004. The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes. Control. Clin. Trials 25, 178-202. (Pubitemid 38328758)
27. Haag, M.D.M., Hofman, A., Koudstaal, P.J., Stricker, B.H.C., Breteler, M.M.B., 2009. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J. Neurol. Neurosurg. Psychiatry 80, 13-17.
28. Hajjar, I., Schumpert, J., Hirth, V., Wieland, D., Eleazer, G.P., 2002. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J. Gerontol. A Biol. Sci. Med. Sci. 57, M414-M418. (Pubitemid 34733805)
29. Horton, J.D., Goldstein, J.L., Brown, M.S., 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131. (Pubitemid 34496588)
30. Iqbal, U., Dringenberg, H.C., Brien, J.F., Reynolds, J.N., 2004. Chronic prenatal ethanol exposure alters hippocampal GABAA receptors and impairs spatial learning in the guinea pig. Behav. Brain Res. 150, 117-125. (Pubitemid 38368963)
31. Javadi-Paydar, M., Rayatnia, F., Fakhraei, N., Zakeri, M., Mirazi, N., Norouzi, A., Dehpour, A.R., 2011. Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide. Brain Res. 1386, 89-99.
32. King, D.S., Wilburn, A.J., Wofford, M.R., Harrell, T.K., Lindley, B.J., Jones, D.W., 2003. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 23 (12), 1663-1667. (Pubitemid 37485319)
33. Kotti, T.J., Ramirez, D.M.O., Pfeiffer, B.E., Huber, K.M., Russell, D.W., 2006. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. U. S. A. 103, 3869-3874. (Pubitemid 43376647)
34. Krause, B.R., Newton, R.S., 1995. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis 117, 237-244.
35. Liao, J.K., Laufs, U., 2004. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89-118.
36. Lutjohann, D., Stroick, M., Bertsch, T., Kuhl, S., Lindenthal, B., Thelen, K., Andersson, U., Bjorkhem, I., Bergmann, K.v., Fassbender, K., 2004. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69, 431-438. (Pubitemid 38829339)
37. Madsen, C.S., Janovitz, E., Zhang, R., Van, N.-T., Ryan, C.S., Yin, X., Monshizadegan, H., Chang, M., D'Arienzo, C., Scheer, S., Setters, R., Search, D., Chen, X., Zhuang, S., Kunselman, L., Peters, A., Harrity, T., Apedo, A., Huang, C., Cuff, C.A., Kowala, M.C., Blanar, M.A., Sun, C.-q., Robl, J.A., Stein, P.D., 2008. The guinea pig as a preclinical model for demonstrating the efficacy and safety of statins. J. Pharmacol. Exp. Ther. 324, 576-586. (Pubitemid 351185833)
38. Malenka, R.C., 2003. The long-term potential of LTP. Nat. Rev. Neurosci. 4, 923-926. (Pubitemid 37351431)
39. Mans, R.A., Chowdhury, N., Cao, D., McMahon, L.L., Li, L., 2010. Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166, 435-444.
40. Mauch, D.H., Nagler, K., Schumacher, S., Goritz, C., Muller, E.-C., Otto, A., Pfrieger, F.W., 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357. (Pubitemid 33063104)
41. McGuinness, B., O'Hare, John, Craig, David, Bullock, Roger, Malouf, Reem, Peter, P., 2010. Statins for the treatment of dementia. Cochrane Database Syst. Rev. 4.
42. Michikawa, M., Yanagisawa, K., 1999. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J. Neurochem. 72, 2278-2285. (Pubitemid 29242177)
43. Morris, R.G.M., 1981. Spatial localization does not require the presence of local cues. Learn. Motiv. 12, 239-260.
44. Moser, E.I., Krobert, K.A., Moser, M.-B., Morris, R.G.M., 1998. Impaired spatial learning after saturation of long-term potentiation. Science 281, 2038-2042. (Pubitemid 28475493)
45. Muller, D., Nikonenko, I., Jourdain, P., Alberi, S., 2002. LTP, memory and structural plasticity. Curr. Mol. Med. 2, 605-611. (Pubitemid 35256292)
46. Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., Janecek, E., Domecq, C., Greenblatt, D.J., 1981. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239-245. (Pubitemid 12149145)
47. Nissen, S.E., 2004. High-dose statins in acute coronary syndromes. JAMA 292, 1365-1367.
48. Noda, Y., Yamada, K., Nabeshima, T., 1997. Role of nitric oxide in the effect of aging on spatial memory in rats. Behav. Brain Res. 83, 153-158. (Pubitemid 27086629)
49. Parle, M., Singh, N., 2007. Reversal of memory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi 127, 1125-1137. (Pubitemid 47035644)
50. Pasternak, R.C., Smith Jr., S.C., Bairey-Merz, C.N., Grundy, S.M., Cleeman, J.I., Lenfant, C., 2002. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J. Am. Coll. Cardiol. 40, 567-572. (Pubitemid 34833176)
51. Pedersen, T.R., 2004. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Atheroscler. Suppl. 5, 81-87.
52. Peters, J.T., Garwood, C.L., Lepczyk, M., 2008. Behavioral changes with paranoia in an elderly woman taking atorvastatin. Am. J. Geriatr. Pharmacother. 6, 28-32. (Pubitemid 351722952)
53. Rayatnia, F., Javadi-Paydar, M., Allami, N., Zakeri, M., Rastegar, H., Norouzi, A., Dehpour, A.R., 2011. Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice. Eur. J. Pharmacol. 666, 122-130.
54. Reagan-Shaw, S., Nihal, M., Ahmad, N., 2007. Dose translation from animal to human studies. 22, 659-661.
55. Reagan-Shaw, S., Nihal, M., Ahmad, N., 2008. Dose translation from animal to human studies revisited. FASEB J. 22, 659-661. (Pubitemid 351348146)
56. Reijneveld, J.C., Koot, R.W., Bredman, J.J., Joles, J.A., Bär, P.R., 1996. Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats. Pediatr. Res. 39.
57. Rex, A., Marsden, C., Fink, H., 1993. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology (Berl) 110, 490-496. (Pubitemid 23074574)
58. Ross, S.D., Allen, I.E., Connelly, J.E., Korenblat, B.M., Smith, M.E., Bishop, D., Luo, D., 1999. Clinical outcomes in statin treatment trials: a meta-analysis. Arch. Intern. Med. 159, 1793-1802. (Pubitemid 29379144)
59. Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L.E.M., Buckley, B.M., Cobbe, S.M., Ford, I., Gaw, A., Hyland, M., Jukema, J.W., Kamper, A.M., Macfarlane, P.W., Meinders, A.E., Norrie, J., Packard, C.J., Perry, I.J., Stott, D.J., Sweeney, B.J., Twomey, G., Westendorp, R.G.J., 2002. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623-1630. (Pubitemid 35379733)
60. Silva, M., Matthews, M.L., Jarvis, C., Nolan, N.M., Belliveau, P., Malloy, M., Gandhi, P., 2007. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin. Ther. 29, 253-260. (Pubitemid 46661859)
61. Simon, P., Dupuis, R., Costentin, J., 1994. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 61, 59-64. (Pubitemid 24097017)
62. Sironi, L., Cimino, M., Guerrini, U., Calvio, A.M., Lodetti, B., Asdente, M., Balduini, W., Paoletti, R., Tremoli, E., 2003. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol. 23, 322-327. (Pubitemid 36231947)
63. Tanaka, N., Katayama, Y., Katsumata, T., Otori, T., Nishiyama, Y., 2007. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. Brain Res. 1169, 125-132. (Pubitemid 47381354)
64. Tatley, M., Savage, R., 2007. Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents. Drug Saf. 30 (3), 195-201. (Pubitemid 46425633)
65. Thelen, K.M., Rentsch, K.M., Gutteck, U., Heverin, M., Olin, M., Andersson, U., von Eckardstein, A., Björkhem, I., Lütjohann, D., 2006. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J. Pharmacol. Exp. Ther. 316, 1146-1152. (Pubitemid 43345288)
66. Tuccori, M., Lapi, F., Testi, A., Coli, D., Moretti, U., Vannacci, A., Motola, D., Salvo, F., Alma Lisa, R., Blandizzi, C., Mugelli, A., Mario Del, T., 2008. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Drug Saf. 31, 1115-1123.
67. Vance, J.E., Hayashi, H., Karten, B., 2005. Cholesterol homeostasis in neurons and glial cells. Semin. Cell Dev. Biol. 16, 193-212. (Pubitemid 40432121)
68. Vrecer, M., Turk, S., Drinovec, J., Mrhar, A., 2003. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int. J. Clin. Pharmacol. Ther. 41, 567-577. (Pubitemid 37527563)
69. Walf, A.A., Frye, C.A., 2007. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322-328. (Pubitemid 47040046)
70. Wang, H., Lynch, J.R., Song, P., Yang, H.-J., Yates, R.B., Mace, B., Warner, D.S., Guyton, J.R., Laskowitz, D.T., 2007. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp. Neurol. 206, 59-69. (Pubitemid 46935123)
71. Wang, C.-Y., Liu, P.-Y., Liao, J.K., 2008. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol. Med. 14, 37-44.
72. Wang, Q., Zengin, A., Deng, C., Li, Y., Newell, K.A., Yang, G.Y., Lu, Y., Wilder-Smith, E.P., Zhao, H., Huang, X.F., 2009. High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the up-regulation of NMDA receptor binding in the rat brain. Exp. Neurol. 216, 132-138.
73. West, K.L., Fernandez, M., 2004. Guinea pigs as models to study the hypocholesterolemic effects of drugs. Cardiovasc. Drug Rev. 22, 55-70. (Pubitemid 38379634)
74. While, A., Keen, L., in press. The effects of statins on mood: a review of the literature. Eur. J. Cardiovasc. Nurs., Corrected Proof.
75. Wierzbicki, A.S., Mikhailidis, D.P., 2002. Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies. Int. J. Cardiol. 84, 53-57. (Pubitemid 34718090)
76. Wilke, R.A., Lin, D.W., Roden, D.M., Watkins, P.B., Flockhart, D., Zineh, I., Giacomini, K.M., Krauss, R.M., 2007. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov. 6, 904-916. (Pubitemid 350042398)
77. Yan, J., Xu, Y., Zhu, C., Zhang, L., Wu, A., Yang, Y., Xiong, Z., Deng, C., Huang, X.-F., Yenari, M.A., Yang, Y.-G., Ying, W., Wang, Q., 2011. Simvastatin prevents dopaminergic neurodegeneration in experimental Parkinsonian models: the association with anti-inflammatory responses. PLoS One 6, e20945.
78. Zandi, P.P., Sparks, D.L., Khachaturian, A.S., Tschanz, J., Norton, M., Steinberg, M., Welsh-Bohmer, K.A., Breitner, J.C.S., Cache County Study, I, 2005. Do statins reduce risk of incident dementia and alzheimer disease?: The Cache County Study. Arch. Gen. Psychiatry 62, 217-224. (Pubitemid 40189139)
79. Zheng, Y., Mason-Parker, S.E., Logan, B., Darlington, C.L., Smith, P.F., Abraham, W.C., 2010. Hippocampal synaptic transmission and LTP in vivo are intact following bilateral vestibular deafferentation in the rat. Hippocampus 20, 461-468.